188 related articles for article (PubMed ID: 36223449)
21. Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy.
Bonacchi M; Nistri S; Nanni C; Gelsomino S; Pini A; Cinci L; Maiani M; Zecchi-Orlandini S; Lorusso R; Fanti S; Silvertown J; Bani D
J Cell Mol Med; 2009 Sep; 13(9B):3437-48. PubMed ID: 18798866
[TBL] [Abstract][Full Text] [Related]
22. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
Mardhian DF; Storm G; Bansal R; Prakash J
J Control Release; 2018 Nov; 290():1-10. PubMed ID: 30287265
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
[TBL] [Abstract][Full Text] [Related]
24. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.
Santora K; Rasa C; Visco D; Steinetz BG; Bagnell CA
J Pharmacol Exp Ther; 2007 Aug; 322(2):887-93. PubMed ID: 17526806
[TBL] [Abstract][Full Text] [Related]
25. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.
Beiert T; Tiyerili V; Knappe V; Effelsberg V; Linhart M; Stöckigt F; Klein S; Schierwagen R; Trebicka J; Nickenig G; Schrickel JW; Andrié RP
Biochem Biophys Res Commun; 2017 Aug; 490(3):643-649. PubMed ID: 28634079
[TBL] [Abstract][Full Text] [Related]
26. Characterization and biological activity of relaxin in porcine milk.
Frankshun AL; Ho TY; Reimer DC; Chen J; Lasano S; Steinetz BG; Bartol FF; Bagnell CA
Reproduction; 2011 Mar; 141(3):373-80. PubMed ID: 21177955
[TBL] [Abstract][Full Text] [Related]
27. Effect of relaxin on myocardial ischemia injury induced by isoproterenol.
Zhang J; Qi YF; Geng B; Pan CS; Zhao J; Chen L; Yang J; Chang JK; Tang CS
Peptides; 2005 Sep; 26(9):1632-9. PubMed ID: 16112403
[TBL] [Abstract][Full Text] [Related]
28. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
Yang X; Thorngren D; Chen Q; Wang M; Xie X
Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
[TBL] [Abstract][Full Text] [Related]
29. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
Yoshida T; Kumagai H; Suzuki A; Kobayashi N; Ohkawa S; Odamaki M; Kohsaka T; Yamamoto T; Ikegaya N
Nephrol Dial Transplant; 2012 Jun; 27(6):2190-7. PubMed ID: 22086971
[TBL] [Abstract][Full Text] [Related]
30. Effect of Relaxin Expression from an Alginate Gel-Encapsulated Adenovirus on Scar Remodeling in a Pig Model.
Yun IS; Kang E; Ahn HM; Kim YO; Rah DK; Roh TS; Lee WJ; Yun CO
Yonsei Med J; 2019 Sep; 60(9):854-863. PubMed ID: 31433583
[TBL] [Abstract][Full Text] [Related]
31. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis.
Samuel CS; Zhao C; Bathgate RA; Bond CP; Burton MD; Parry LJ; Summers RJ; Tang ML; Amento EP; Tregear GW
FASEB J; 2003 Jan; 17(1):121-3. PubMed ID: 12424226
[TBL] [Abstract][Full Text] [Related]
32. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease.
Mookerjee I; Solly NR; Royce SG; Tregear GW; Samuel CS; Tang ML
Endocrinology; 2006 Feb; 147(2):754-61. PubMed ID: 16254028
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: an electrophysiological study.
Squecco R; Sassoli C; Garella R; Chellini F; Idrizaj E; Nistri S; Formigli L; Bani D; Francini F
Exp Physiol; 2015 Jun; 100(6):652-66. PubMed ID: 25786395
[TBL] [Abstract][Full Text] [Related]
34. The relaxin gene-knockout mouse: a model of progressive fibrosis.
Samuel CS; Zhao C; Bathgate RA; DU XJ; Summers RJ; Amento EP; Walker LL; McBurnie M; Zhao L; Tregear GW
Ann N Y Acad Sci; 2005 May; 1041():173-81. PubMed ID: 15956703
[TBL] [Abstract][Full Text] [Related]
35. The relaxin gene knockout mouse: a model of progressive scleroderma.
Samuel CS; Zhao C; Yang Q; Wang H; Tian H; Tregear GW; Amento EP
J Invest Dermatol; 2005 Oct; 125(4):692-9. PubMed ID: 16185267
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the local expression of the relaxin system in canine mammary tumours.
Lamp O; Honscha KU; Jakob J; Lamp J; Schweizer S; Reischauer A; Gottschalk J; Hahn A; Ebert M; Rothemund S; Blaschzik S; Einspanier A
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():224-9. PubMed ID: 19754574
[TBL] [Abstract][Full Text] [Related]
37. Effects of relaxin on development of mesangial proliferative nephritis.
Ikegaya N; Yoshida T; Kohsaka T; Suzuki A; Kobayashi N; Yamamoto T; Fujigaki Y; Hishida A; Kumagai H
Ann N Y Acad Sci; 2009 Apr; 1160():300-3. PubMed ID: 19416208
[TBL] [Abstract][Full Text] [Related]
38. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
[TBL] [Abstract][Full Text] [Related]
39. Relaxin gene therapy: A promising new treatment option for various diseases with aberrant fibrosis or irregular angiogenesis.
Hong J; Yun CO
Mol Cell Endocrinol; 2019 May; 487():80-84. PubMed ID: 30641100
[TBL] [Abstract][Full Text] [Related]
40. Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy.
Samuel CS; Hewitson TD; Zhang Y; Kelly DJ
Endocrinology; 2008 Jul; 149(7):3286-93. PubMed ID: 18388190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
